Literature DB >> 2832796

Sodium/potassium-adenosine triphosphatase on erythrocyte ghosts from pregnant women and its relationship to pregnancy-induced hypertension.

A L Tranquilli1, L Mazzanti, E Bertoli, C Romanini.   

Abstract

The regulation of electrolytes has been proposed as a possible determinant in hypertensive conditions, including pregnancy-induced hypertension. We report a study of sodium/potassium-adenosine triphosphatase in erythrocyte membranes of 59 patients with pregnancy-induced hypertension and 48 normotensive pregnant controls. The kinetics of the enzyme were also investigated, and the enzyme activity related to different degrees of pathology. A marked reduction of the enzyme activity was found in hypertensive patients, compared with controls. This reduction was greater when hypertension was associated with worse prognostic signs, such as proteinuria. These features are in agreement with the increased sodium content and the increased vascular reactivity found in pregnancy-induced hypertension. The enzyme activity appears to be decreased by means of a conformational modification of the enzyme sites, a phenomenon related to the hypertensive condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832796

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Morpho-functional modifications of human syncytiotrophoblast plasma membrane during pregnancy induced hypertension.

Authors:  G Biagini; E Salvolini; A Pugnaloni; R A Rabini; N Cester; C Romanini; R Staffolani; L Mazzanti
Journal:  Mol Cell Biochem       Date:  1995-10-04       Impact factor: 3.396

2.  Erythrocyte sodium/potassium ATPase activity in severe preeclampsia.

Authors:  C D Adair; G T Haupert; H P Koh; Y Wang; J-C Veille; V Buckalew
Journal:  J Perinatol       Date:  2009-01-22       Impact factor: 2.521

3.  Insulin changes in preeclamptic women during pregnancy.

Authors:  Shohreh Malek-Khosravi; Bijan Kaboudi
Journal:  Ann Saudi Med       Date:  2004 Nov-Dec       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.